Search Results
PAOLA-1 Phase 3 data: olaparib plus bevacizumab maintenance for advanced ovarian cancer
Final OS results from PAOLA-1 evaluating 1L maintenance olaparib plus bevacizumab
Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial
Maintenance Therapy in Ovarian Cancer
The PAOLA-1 study: olaparib and bevacizumab for ovarian cancer
Implications of PAOLA-1 in Advanced Ovarian Cancer
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer
ESMO 2019 PAOLA Trial
Updates in Ovarian Cancer: Frontline Maintenance
ESMO 2020 Expert Video Report on studying further advanced ovarian cancer
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
#ESMO19: Positive Trial for Ovarian Cancer: PAOLA-1/ENGOT-ov25
